Finding of Strongyloides stercoralis infection, 25 years after leaving the endemic area, upon corticotherapy for ocular trauma;Découverte d'une infestation à Anguillule, 25 ans après retour de zone d'endémie, à l'occasion d'une corticothérapie pour traumatisme oculaire

Journal Francais d'Ophtalmologie

Volumn 30, Issue 2, 2007, Pages

  Guyomard, J L ^a   Chevrier, S ^a   Bertholom, J L ^a   Guigen, C ^a   Charlin, J F ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Corticotherapy; Strongyloides stercoralis; Strongyloidiasis

Indexed keywords

CORTICOSTEROID;

ADULT; ANIMAL; ARTICLE; CASE REPORT; ENTEROPATHY; HUMAN; MALE; PAPILLEDEMA; PARASITOLOGY; RECURRENT DISEASE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

ADRENAL CORTEX HORMONES; ADULT; ANIMALS; HUMANS; INTESTINAL DISEASES; MALE; PAPILLEDEMA; RECURRENCE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 33847273604     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Magnaval JF, Mansuy JM, Villeneuve L, Cassaing S. A retrospective study of autochthonous strongyloidiasis in Region Midi-Pyrenees (Southwestern France). Eur J Epidemiol, 2000;16:179-82.
2. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis, 1981;3:397-407.
3. Genta RM. Dysregulation of strongyloidiasis: a new hypothesis. Clin Microbiol Rev, 1992;5:345-55.
4. Gordon SM, Gal AA, Solomon AR, Bryan JA. Disseminated strongyloidiasis with cutaneous manifestations in an immunocompromised host. J Am Acad Dermatol, 1994;31(Pt 1):255-9.
5. Kinjo T, Tsuhako K, Nakazato I, Ito E, Sato Y, Koyanagi Y, et al. Extensive intra-alveolar haemorrhage caused by disseminated strongyloidiasis. Int J Parasitol, 1998;28:323-30.
6. Leelarasamee A, Nimmannit S, Na Nakorn S, Aswapokee N, Aswapokee P, Benjasuratwong Y. Disseminated strongyloidiasis: report of seven cases. Southeast Asian J Trop Med Public Health, 1978;9:539-42.
7. Thomas MC, Costello SA. Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int J Clin Pract, 1998;52:520-1.
8. West BC, Wilson JP. Subconjunctival corticosteroid therapy complicated by hyperinfective strongyloidiasis. Am J Ophthalmol, 1980;89:854-7.
9. O'Day DM, McKenna TJ and Elliot JH. Ocular corticosteroid therapy. Systemic hormonal effects. Trans Am Acad Ophthalmol Otolaryngol, 1975;79:71
10. Bouree P, Taugourdeau A, Barthelemy M, Pequignot-Ricome H, Passeron J, Bouvier JB. [Strongyloidiasis: a clinical, biological and epidemiological study of 350 cases (author's transl)]. Nouv Presse Med, 1981;10:679-81.
11. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis, 1989;11:755-67.
12. Kaslow JE, Novey HS, Zuch RH, Spear GS. Disseminated strongyloidiasis: an unheralded risk of corticosteroid therapy. J Allergy Clin Immunol, 1990;86:138.
13. Kramer MR, Gregg PA, Goldstein M, Llamas R, Krieger BP. Disseminated strongyloidiasis in AIDS and non-AIDS immunocompromised hosts: diagnosis by sputum and bronchoalveolar lavage. South Med J, 1990;83:1226-9.
14. Wijesundera MD, Sanmuganathan PS. Ivermectin therapy in chronic strongyloidiasis. Trans R Soc Trop Med Hyg, 1992;86:291.